• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

Introduction to (S)-1-(Thiazol-2-yl)ethanamine (CAS No. 623143-42-0)

(S)-1-(Thiazol-2-yl)ethanamine, also known by its CAS number 623143-42-0, is a compound of significant interest in the fields of organic chemistry and pharmacology. This compound belongs to the class of thiazole derivatives, which have been extensively studied due to their diverse biological activities and potential applications in drug discovery. The molecule features a thiazole ring, a five-membered heterocycle containing sulfur and nitrogen atoms, attached to an ethanamine group with an (S)-configuration at the chiral center. This stereochemistry is crucial for its biological activity, as it often determines the compound's interaction with target proteins.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of (S)-1-(Thiazol-2-yl)ethanamine. Researchers have explored various methodologies, including asymmetric catalysis and enantioselective synthesis, to produce this compound with high optical purity. These methods not only enhance the yield but also ensure the reproducibility of the compound, making it more accessible for further studies. The synthesis typically involves the formation of the thiazole ring through condensation reactions, followed by the introduction of the ethanamine group via nucleophilic substitution or other suitable reactions.

The physical properties of (S)-1-(Thiazol-2-yl)ethanamine are well-documented. It is a white crystalline solid with a melting point of approximately 150°C. The compound is sparingly soluble in water but exhibits good solubility in organic solvents such as dichloromethane and ethanol. Its molecular weight is around 157 g/mol, and its density is about 1.3 g/cm3. These properties make it suitable for various analytical techniques, including high-performance liquid chromatography (HPLC) and mass spectrometry (MS), which are commonly used for its characterization.

In terms of biological activity, (S)-1-(Thiazol-2-yl)ethanamine has shown promising results in recent studies. It has been evaluated for its potential as an anti-inflammatory agent, where it demonstrated significant inhibitory effects on pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Additionally, the compound has been investigated for its antioxidant properties, which could be beneficial in combating oxidative stress-related diseases such as neurodegenerative disorders and cardiovascular diseases.

The stereochemistry of (S)-1-(Thiazol-2-yl)ethanamine plays a pivotal role in its pharmacokinetic profile. Studies have shown that the (S)-enantiomer exhibits better absorption and bioavailability compared to its (R)-counterpart. This highlights the importance of chirality in drug design and underscores the need for enantioselective synthesis methods to produce therapeutic agents with optimal pharmacokinetic properties.

Recent research has also explored the use of (S)-1-(Thiazol-2-yl)ethanamine as a building block in medicinal chemistry. Its thiazole ring serves as a versatile scaffold for further functionalization, enabling the creation of novel bioactive molecules. For instance, researchers have appended various substituents to the thiazole ring to enhance its binding affinity to specific targets or to improve its pharmacokinetic properties.

In conclusion, (S)-1-(Thiazol-2-yl)ethanamine (CAS No. 623143-42-0) is a valuable compound with significant potential in drug discovery and development. Its unique structure, coupled with its stereochemical properties, makes it an attractive candidate for further research. As advancements in synthetic chemistry continue to evolve, we can expect even more innovative applications of this compound in the near future.

• 473733-53-8(1-(1,3-thiazol-2-yl)-1-propanamine)
• 623143-43-1((R)-1-(Thiazol-2-yl)ethanamine)
• 1417793-59-9(N,N-Dimethyl-1-(thiazol-2-yl)ethanamine)
• 165668-13-3(Formamide,N-[1-(2-thiazolyl)ethyl]-)
• 1211514-66-7(N-1-(1,3-thiazol-2-yl)ethylcyclopropanamine)
• 933682-50-9(N-methyl-1-(1,3-thiazol-2-yl)ethanamine)
• 432047-36-4(1-thiazol-2-ylethanamine)
• 1082393-38-1(2-(1,3-Thiazol-2-yl)propan-2-amine)
• 92932-33-7(1-(1,3-thiazol-2-yl)ethylamine dihydrochloride)
• 947662-64-8(1-thiazol-2-ylethanamine;hydrochloride)